SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-22-001515
Filing Date
2022-02-17
Accepted
2022-02-17 16:17:56
Documents
1
Period of Report
2022-02-15

Document Format Files

Seq Description Document Type Size
1 form4-02172022_010228.html 4  
1 form4-02172022_010228.xml 4 6187
  Complete submission text file 0001415889-22-001515.txt   7674
Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BLACK DIAMOND THERAPEUTICS, INC. ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address
Jones Erika (Reporting) CIK: 0001895913 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 22648342